SpyBiotech
Infectious Disease Therapeutics · Vaccines
Overview
SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and chronic diseases.
Funding and backers
Team
11-50
employees, estimated range
Backers
2
GV, Oxford Science Enterprises
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
TareBio develops vaccines for cancer and infectious diseases by decoding immune responses to engineer targeted antigens.
Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…
Abogen Biosciences is a Chinese clinical-stage biopharmaceutical company developing messenger RNA (mRNA) medicines with its own mRNA and…
Genvax Technologies is an animal vaccine company developing next-generation mRNA + nanoparticle vaccines from Ames, Iowa. Our mission is to…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Oxford Science EnterprisesVia a fund
GVVia a fund
569 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely